title: [The Possibility of Using Myocardial Cytoprotector Tiotriazoline in Cardiology Practice].
abstract: The improvement of approaches to the treatment of cardiovascular diseases is considered the number of primary concerns of modern cardiology. It is undoubtable that the main achievements of the last few decades are creation and introduction into clinical practice of metabolic drugs, which mechanism of action is assotiated with influence on basic pathogenesis of cardiovascular diseases. Myocardial cytoprotector tiotriazoline is one of the most active agents of this class of drugs. The medication shows antiischemic, antioxidant, membrane stabilizing and immunomodulatory effects. Results of experimental and clinical investigations performed by nowdays have demonstrated safety and efficacy of Tiotriazoline, especially in treatment of coronary heart disease.
authors.affiliation: Central State Medical Academy, President Management Department RF, Moscow, Russia.
authors.forename: N M
authors.initials: NM
authors.lastname: Savina
mesh_terms: D002309:Cardiology; D003327:Coronary Disease / Q000188:drug therapy / Q000473:pathology; D019610:Cytoprotection; D006321:Heart / Q000187:drug effects; D006801:Humans; D014230:Triazoles / Q000627:therapeutic use*
chemical_list: D014230:Triazoles